ADC Therapeutics (ADCT) Revenue (2021 - 2026)
ADC Therapeutics (ADCT) posted Revenue of $20.9 million for Q1 2026, up 26.93% sequentially from $16.4 million in Q3 2025, and down 9.47% YoY from $23.0 million in Q1 2025.
ADC Therapeutics (ADCT) Revenue (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Revenue for 6 years, with the latest figure at $20.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 674.14 Mn |
| 10 | ADC Therapeutics | 152.54 Mn | -66.57 Mn | 17.14 Mn | 19.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.25 Mn |
| Mar 31, 2026 | 20.85 Mn |
| Sep 30, 2025 | 16.43 Mn |
| Jun 30, 2025 | 18.84 Mn |
| Mar 31, 2025 | 23.03 Mn |
| Sep 30, 2024 | 18.46 Mn |
| Jun 30, 2024 | 17.41 Mn |
| Mar 31, 2024 | 18.05 Mn |
| Sep 30, 2023 | 14.49 Mn |
| Jun 30, 2023 | 19.28 Mn |
| Mar 31, 2023 | 18.99 Mn |
| Sep 30, 2022 | 76.32 Mn |
| Jun 30, 2022 | 17.29 Mn |
| Mar 31, 2022 | 46.50 Mn |
| Sep 30, 2021 | 13.15 Mn |
| Jun 30, 2021 | 3.76 Mn |